Georgina Kerr

As Senior Programme Manager for the Oxford-GSK Institute of Molecular and Computational Medicine (IMCM), I am responsible for ensuring the smooth running of this large, multi-disciplinary collaboration. I provide overall operational leadership, financial control and drive productive interactions between Oxford, GSK and other strategic partners within the Institute. Working closely with colleagues at Oxford and GSK I am responsible for the development of project plans for the joint projects, including identifying risks and implementing strategies to mitigate them, collating milestones, objectives and deliverables and ensuring the collaboration proceeds according to tight deadlines.

Prior to my current role I was the Research Facilitator for Immunology within the Medical Sciences Division and established the Immunology Network to coordinate and communicate immunology-related research across the University. Immunology research encompasses a wide range of subjects areas and researchers are spread across a number of sites and departments within the University. The Immunology Network aims to promote the sharing of ideas, expertise and resources within Oxford, and to facilitate collaborations, identify funding opportunities and support research innovation.

Before transitioning into Research Administration I worked as a post-doctoral scientist at the University of Oxford initially at the Weatherall Institute of Molecular Medicine using biochemical assays to understand more about the cancer-predisposition disorder Bloom’s Syndrome, and subsequently at the Structural Genomics Consortium where I used cell-based assays to validate potential drug-like molecules in the treatment of the rare bone disease Fibrodysplasia Ossificans Progressiva (FOP), also known as Stone Man Syndrome. I completed my PhD at the MRC Laboratory of Molecular Biology in Cambridge under the supervision of KJ Patel.